Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP892527.RA-NjSMWlmFufJ-u9HcSTefNkJpMeC4sgEC1BSUBaQe9E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP892527.RA-NjSMWlmFufJ-u9HcSTefNkJpMeC4sgEC1BSUBaQe9E130_assertion type Assertion NP892527.RA-NjSMWlmFufJ-u9HcSTefNkJpMeC4sgEC1BSUBaQe9E130_head.
- NP892527.RA-NjSMWlmFufJ-u9HcSTefNkJpMeC4sgEC1BSUBaQe9E130_assertion description "[Three of five candidate vulnerability genes (RASD2, APOL5, MYH9, EIF3S7, and CACNG2), which had marginally significant associations with schizophrenia, had significant associations with schizophrenic patients who did not have deficits in sustained attention on the undegraded CPT (RASD2 gene SNP rs736212; p = .0008 with single locus analysis) and the degraded CPT (MYH9 gene haplotype 1-1-1-1 of SNP rs3752463 - rs1557540 - rs713839 - rs739097; p = .0059 with haplotype analysis).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892527.RA-NjSMWlmFufJ-u9HcSTefNkJpMeC4sgEC1BSUBaQe9E130_provenance.
- NP892527.RA-NjSMWlmFufJ-u9HcSTefNkJpMeC4sgEC1BSUBaQe9E130_assertion evidence source_evidence_literature NP892527.RA-NjSMWlmFufJ-u9HcSTefNkJpMeC4sgEC1BSUBaQe9E130_provenance.
- NP892527.RA-NjSMWlmFufJ-u9HcSTefNkJpMeC4sgEC1BSUBaQe9E130_assertion SIO_000772 18571626 NP892527.RA-NjSMWlmFufJ-u9HcSTefNkJpMeC4sgEC1BSUBaQe9E130_provenance.
- NP892527.RA-NjSMWlmFufJ-u9HcSTefNkJpMeC4sgEC1BSUBaQe9E130_assertion wasDerivedFrom befree-20140225 NP892527.RA-NjSMWlmFufJ-u9HcSTefNkJpMeC4sgEC1BSUBaQe9E130_provenance.
- NP892527.RA-NjSMWlmFufJ-u9HcSTefNkJpMeC4sgEC1BSUBaQe9E130_assertion wasGeneratedBy ECO_0000203 NP892527.RA-NjSMWlmFufJ-u9HcSTefNkJpMeC4sgEC1BSUBaQe9E130_provenance.